IRON
Price
$59.38
Change
+$1.61 (+2.79%)
Updated
Jul 21 closing price
Capitalization
2.06B
17 days until earnings call
VRNA
Price
$104.90
Change
-$0.00 (-0.00%)
Updated
Jul 21 closing price
Capitalization
8.93B
9 days until earnings call
Interact to see
Advertisement

IRON vs VRNA

Header iconIRON vs VRNA Comparison
Open Charts IRON vs VRNABanner chart's image
Disc Medicine
Price$59.38
Change+$1.61 (+2.79%)
Volume$554.66K
Capitalization2.06B
Verona Pharma
Price$104.90
Change-$0.00 (-0.00%)
Volume$2.73M
Capitalization8.93B
IRON vs VRNA Comparison Chart in %
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. VRNA commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Buy and VRNA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (IRON: $59.38 vs. VRNA: $104.90)
Brand notoriety: IRON and VRNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 150% vs. VRNA: 66%
Market capitalization -- IRON: $2.06B vs. VRNA: $8.93B
IRON [@Biotechnology] is valued at $2.06B. VRNA’s [@Biotechnology] market capitalization is $8.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileVRNA’s FA Score has 1 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • VRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IRON and VRNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 4 TA indicator(s) are bullish while VRNA’s TA Score has 4 bullish TA indicator(s).

  • IRON’s TA Score: 4 bullish, 3 bearish.
  • VRNA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IRON is a better buy in the short-term than VRNA.

Price Growth

IRON (@Biotechnology) experienced а +2.84% price change this week, while VRNA (@Biotechnology) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

IRON is expected to report earnings on Aug 08, 2025.

VRNA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRNA($8.93B) has a higher market cap than IRON($2.06B). VRNA YTD gains are higher at: 125.883 vs. IRON (-6.341). IRON has higher annual earnings (EBITDA): -114.41M vs. VRNA (-121.41M). IRON has more cash in the bank: 695M vs. VRNA (401M). IRON has less debt than VRNA: IRON (30.6M) vs VRNA (244M). VRNA has higher revenues than IRON: VRNA (119M) vs IRON (0).
IRONVRNAIRON / VRNA
Capitalization2.06B8.93B23%
EBITDA-114.41M-121.41M94%
Gain YTD-6.341125.883-5%
P/E RatioN/AN/A-
Revenue0119M-
Total Cash695M401M173%
Total Debt30.6M244M13%
FUNDAMENTALS RATINGS
VRNA: Fundamental Ratings
VRNA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
2
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRONVRNA
RSI
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 5 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 5 days ago
79%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
81%
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 5 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOWFX17.220.09
+0.53%
Towpath Focus Institutional
SMGIX38.430.11
+0.29%
Columbia Contrarian Core Inst
MERFX18.14N/A
N/A
The Merger Fund A
NSVAX13.46-0.04
-0.30%
Columbia Small Cap Value II Inst
FSCVX25.85-0.10
-0.39%
Nuveen Small Cap Value C

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with CGON. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+2.79%
CGON - IRON
52%
Loosely correlated
-5.48%
CRNX - IRON
51%
Loosely correlated
-0.51%
IDYA - IRON
50%
Loosely correlated
+1.02%
SYRE - IRON
50%
Loosely correlated
+0.37%
KMSTF - IRON
49%
Loosely correlated
N/A
More

VRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNA has been loosely correlated with RYTM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VRNA jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNA
1D Price
Change %
VRNA100%
N/A
RYTM - VRNA
44%
Loosely correlated
-0.64%
ZYME - VRNA
43%
Loosely correlated
+0.49%
IRON - VRNA
41%
Loosely correlated
+2.79%
ARCT - VRNA
41%
Loosely correlated
+2.15%
CRNX - VRNA
41%
Loosely correlated
-0.51%
More